News
Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
The investigational dual GLP-1 and amylin receptor agonist Amycretin demonstrated significant weight loss-up to 24% with ...
The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...
Tirzepatide has emerged as the most effective treatment for lowering blood sugar and promoting weight loss in people with ...
Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results